Altimmune, Inc. (ALT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.42+5.88%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | — | 0.0 | 0.0 | 0.4 |
| Total Revenues | — | 0.0 | 0.0 | 0.4 |
| Operating Expenses & Income | ||||
| R&D Expenses | 68.2 | 66.4 | 82.2 | 65.8 |
| Operating Income | (100.2) | (94.5) | (103.2) | (95.9) |
| Earnings from Continuing Operations | ||||
| Interest Expense | — | 1.6 | 0.0 | 0.0 |
| Interest & Investment Income | 12.3 | 7.5 | 8.1 | 7.4 |
| Net Interest Expenses | — | — | — | (7.3) |
| Other Non-Operating Income / Expenses | 8.5 | 5.7 | 8.1 | 7.5 |
| EBT, Incl. Unusual Items | (91.8) | (88.8) | (95.1) | (88.4) |
| Income Tax Expense | — | (0.7) | — | — |
| Net Income | ||||
| Net Income | (91.8) | (88.1) | (95.1) | (88.4) |
| Per Share | ||||
| Basic EPS | (0.49) | (1.00) | (1.34) | (1.66) |
| Diluted EPS | (0.49) | (1.00) | (1.34) | (1.66) |
| Basic Weighted Avg Shares | 185.4 | 88.1 | 71.0 | 53.2 |
| Diluted Weighted Avg Shares | 185.4 | 88.1 | 71.0 | 53.2 |
| Supplemental | ||||
| EBIT | (100.2) | (94.5) | (103.2) | (95.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.